Background: Apo3A restricts HIV-1 in myeloid cells and mutates genomic DNA.
Results: Optimal Apo3A activity and narrow deamination specificity occur at acidic pH; weak activity and broad specificity, featuring CC → TT mutations, occur at physiological pH.
Conclusion: The pH-dependent catalytic properties of Apo3A reflect targeting of HIV-1 cDNA and “off targeting” of genomic DNA.
Significance: Apo3A enzymology provides a molecular basis to elucidate viral exclusion and cancer induction.
Keywords: DNA Damage, HIV-1, Mutagenesis, Myeloid Cell, Nucleic Acid Enzymology, APOBEC, Deoxycytidine Deaminase, Skin Cancer
Abstract
Human deoxycytidine deaminase APOBEC3A (Apo3A) acts as an HIV-1 restriction factor in cells of myeloid lineage yet functions separately as a potent mutator for genomic DNA. Apo3A activity and C motif deamination specificity exhibit a striking dependence on pH that reflects these two distinct biological processes. Upon infection of macrophages, HIV-1 induces the formation of autophagosomes, and requires autophagosomes for replication, whereas inhibiting lysosomal fusion indicative of late stage autophagy. Here we show that Apo3A has optimal activity and a strict 5′-YYCR motif specificity in the pH 5.8–6.1 range, characteristic of enclosed autophagosomal membrane compartments, and reflective of the mutation pattern of HIV-1. In contrast to the high activity and narrow specificity of Apo3A at acid pH, a 13–30-fold reduction in specific activity is accompanied by relaxed C deamination specificity at pH 7.4–8. Notably, Apo3A is also expressed in keratinocytes, and is up-regulated in skin lesions. At pH 7.9, we show that Apo3A generates transcription-dependent CC → TT tandem mutations on the non-transcribed strand, a hallmark signature of skin cancer. The biochemical data taken in conjunction with the biological up-regulation of Apo3A in skin lesions suggests that enzyme-catalyzed deaminations at adjacent C sites followed by normal replication generating CC → TT mutations provides an alternative molecular basis for the initiation events in skin cancer in contrast to well established pathways in which CC dimers formed in response to UV radiation either undergo nonenzymatic spontaneous deaminations or aberrant replication.
Introduction
Activation-induced deoxycytidine deaminase (AID)2 and APOBEC3G (Apo3G), two extensively studied members of the APOBEC family of C deaminases, catalyze the deamination of C → U on single-stranded (ss) DNA (1, 2), AID to initiate somatic hypermutation and class switch recombination in B cells during transcription of immunoglobulin variable genes and switch regions (3, 4), Apo3G to initiate hypermutation on HIV-1 cDNA in T cells lacking the viral infectivity factor vif (5–7). More generally, the APOBEC deaminases can act to provide innate resistance against retroviruses and endogeneous retroelements in a variety of cells (2).
Although most studies on antiretroviral activity of APOBEC proteins have been centered on Apo3G, recent data show that Apo3A is an important restrictive factor for HIV-1 and other primate lentiviruses. Although Apo3G functions most effectively in T-cells, Apo3A has antiviral activity in blood cells of myeloid lineage (8–10), and is highly expressed in myeloid cells, monocytes, dendritic cells, and macrophages (8–10). Apo3A is likely to be functionally important in humans based on two salient observations: first, siRNA-mediated down-regulation of Apo3A in monocytes and macrophages render them considerably more vulnerable to infection by HIV-1 (8, 9); second, treatment of myeloid cells with interferon-α (IFNα) markedly enhances cell resistance to HIV-1 infection (11, 12) coincident with an induction of Apo3A expression by as much as 3 orders of magnitude (8, 13–16).
Apo3A functions not just in the cytoplasm of myeloid cells, but when overexpressed in a variety of cultured cells it mutates nuclear and mitochondrial DNA (17–20). Although Apo3A acts against HIV-1 in its natural myeloid cellular setting, its overexpression inhibits replication of many viruses including papilloma (21), adenoassociated (13, 22), Rous sarcoma (23), T-lymphotropic type 1 (24), degrades foreign DNA (25), and blocks retrotransposition of LINE-1, Alu, and TLR (13, 26–28). Apo3A when overexpressed can be cytotoxic by inducing strand breaks in genomic DNA that activate damage response causing cell-cycle arrest (17, 18, 29–31). It has recently been reported that endogenous Apo3A can be prevented from entering nuclei, but a mechanism has not been identified (18). If entry into nuclei does occur, then to protect against potential inadvertent action of Apo3A, an interaction between the TRIB3 protein and Apo3A prevents deamination of genomic DNA, promotes enzyme degradation, thereby eliminating cytotoxicity (17).
APOBEC proteins require tight cellular regulation to prevent C deaminations in DNA from occurring at the wrong place or time; “off targeted” mutations by AID can cause B-cell lymphoma (32, 33), whereas inadvertent action of Apo3B has recently been implicated in breast cancer (30). Apo3A is expressed in skin keratinocytes (21, 34, 35) possibly to counteract viral infections. However, its overexpression in inflamed skin tissues, acne or psoriasis (34, 35), by the “law of unintended consequences” has the potential to turn normally benign skin lesions into precancerous lesions, leading to full-blown cancer (21).
A biochemical analysis of Apo3A activity and motif deamination specificity at acidic pH, corresponding to enclosed autophagosomal membrane compartments, and at physiological pH, corresponding to cell nuclei, indicates the presence of a dual mutagenic mechanism that might link disparate HIV-1 inactivation in myeloid cells and susceptibility to skin cancer in precancerous skin lesions.
EXPERIMENTAL PROCEDURES
Materials
DNA substrates were synthesized using an Applied Biosystem 3400 DNA synthesizer and purified by denaturing PAGE. T7 RNA polymerase was purchased from Promega and ultrapure rNTPs from GE Healthcare. M13mp2-gapped substrate DNA was prepared as described (36). M13mp2T7 closed circular dsDNA substrate containing a T7 promoter at the 5′-side of the lacZα reporter gene was constructed by site-directed mutagenesis. Reaction buffers (pH 5.1 to 7.4) used for Apo3A deamination activity and DNA binding were as follows: 10 mm sodium cacodylate (pH 5.1, 5.5, 6.5, or 7.4), 1 mm dithiothreitol, 0.5 mm EDTA, and 25 mm NaCl. For the reaction buffer at pH 8.0, 10 mm Tris (pH 8.0) was used instead of 10 mm sodium cacodylate.
Apo3A Purification
A plasmid for expression of Apo3A protein in baculovirus-infected Sf9 insect cells was constructed by cloning the coding portion of Apo3A into the pAcG2T vector (BD Biosciences). Recombinant virus was obtained by co-transfection of pAcG2T-Apo3A and linearized baculovirus DNA (BD Biosciences) into Sf9 insect cells (Invitrogen). Apo3A was expressed in Sf9 insect cells following infection with the recombinant baculovirus at a multiplicity of infection of 3 and harvested after 72 h. Cells harvested from 2-liter cultures were suspended in 50 ml of insect cell lysis buffer (10 mm HEPES, pH 7.5, 150 mm NaCl, 0.1% Triton X-100, 10 mm NaF, 10 mm NaH2PO4, 10 mm Na4P2O7, 1 mm EDTA, 1 mm dithiothreitol, 50 μg/ml of RNase A, 10% glycerol and protease inhibitor) and lysed by sonication. The crude lysate, containing soluble GST-Apo3A was collected after centrifugation at 12,000 × g for 30 min followed by incubation with glutathione-Sepharose resin (GE Healthcare) at 4 °C overnight. After extensive washing with PBS buffer, 120 units of thrombin (Calbiochem) were incubated for 6 h at room temperature to cleave the GST tag. Apo3A, containing extra six amino acids (GSPGID) at its N terminus, was eluted and concentrated using an Ultracel-10K filter unit (Millipore) and applied to a Superdex 75 gel filtration column (GE Healthcare), equilibrated with GF buffer (20 mm Tris, pH 7.5, 250 mm NaCl, 1 mm dithiothreitol, and 0.5 mm EDTA). Fractions containing chromatographically homogeneous Apo3A were pooled (Fig. 1, A and B), dialyzed in GF buffer containing 10% glycerol, concentrated to 10–30 mg/ml using Ultracel-10K, and stored at −80 °C.
FIGURE 1.
pH-dependent activity of Apo3A. A, denaturing PAGE chromatography of human Apo3A expressed and purified from baculovirus-infected Sf9 cells. Apo3A was purified as described under “Experimental Procedures.” The Apo3A gel band shown at the right was obtained by loading 2 μg of protein obtained from the final purification step of gel filtration with Superdex-75. Molecular mass marker bands are shown on the left. B, the Superdex-75 elution profiles for Apo3A and standard molecular marker proteins are shown, with each elution peak and molecular mass (kDa) indicated by arrows. C, the deamination activity of Apo3A was measured as a function of pH using a fluorescein-labeled (F) 65-nt ssDNA containing two favored TC motifs, situated toward the 5′- and 3′-ssDNA ends (top schematic). Apo3A (5 nm) was incubated with the substrate ssDNA (500 nm) for 1, 2, 5, or 10 min. The ssDNA was treated with UDG and hot alkali, and the products were separated by 16% denaturing PAGE. Products of single deamination at the 5′-site (5′), 3′-site (3′), or double deaminations at both sites (5′ and 3′) were detected as 54-, 43-, and 32-nt cleaved products, respectively. D, comparison of Apo3A specific activity (pmol min−1 μg−1) acting on ssDNA substrates at pH 5.1, 5.5, 6.5, 7.4, and 8.0. Error bars represent ± S.E. obtained from 3 independent measurements. The chromatographic gel in A was stained with Coomassie Brilliant Blue.
Deamination Assay to Measure Apo3A Specific Activity on ssDNA
The C-deamination activity of Apo3A was measured at different pH values using a 65-nt fluorescein-labeled (FdT) ssDNA substrate, 5′-GAGTGTTGTTCATAATGTGTGTTGGTT(FdT)ATGTAGAGTGTTGTTCATAATGTGTGTTGGTAGAAAG-3′. For reactions at pH 5.1, 5.5, and 6.5, 500 nm labeled ssDNA was incubated with 5 nm Apo3A in the reaction buffer (30 μl) at 37 °C. For reactions at pH 7.4 and 8.0, a higher concentration (50 nm) of Apo3A was used. After incubations for 1, 2, 5, and 10 min, the reactions were quenched by a double extraction with phenol:chloroform:isoamyl alcohol (25:24:1) followed by a buffer exchange to 10 mm Tris (pH 7.4) using a Micro Bio-spin P-6 column (Bio-Rad). Deaminated products were treated with 1.5 units of uracil:DNA:glycosylase (New England Biolabs) for 30 min at 37 °C followed by incubation at 95 °C for 5 min in the presence of 0.1 n NaOH to cleave the abasic sites resulting from the removal of U. Cleaved deaminated products were separated on a 16% denaturing PAGE gel, visualized, and quantified using an FX fluorescence scanner (Bio-Rad). Products of single deamination at the 5′-side (5′), the 3′-side (3′) target, or double deaminations at both sites (5′ and 3′) were detected as 54, 43, and 32 nt cleaved products, respectively. Specific activity, defined as picomole of deaminated C/min/μg of enzyme was calculated in the linear range of Apo3A concentration and time, using 1 to 2 min incubation times.
Steady-state Rotational Anisotropy Binding Assay
Apo3A binding to ssDNA was monitored by changes in steady-state fluorescence depolarization (rotational anisotropy) (37). Fluorescein-labeled (F) ssDNA (5 to 65 nt), dsDNA (37 nt), and duplex DNA containing single-stranded “bubble” regions (1, 3, and 7 nt) were used as substrates for Apo3A binding. Reaction mixtures (200 μl), containing fluorescein-labeled DNA (50 nm), at the pH values indicated, were incubated with Apo3A at room temperature, at the enzyme concentrations indicated. Rotational anisotropy was measured using a QuantaMaster QM-1 fluorometer (Photon Technology International) with a single emission channel. Samples were excited with vertically polarized light at 494 nm, and both vertical and horizontal emission was monitored at 520 nm (5-nm bandwidth). The microscopic dissociation constant (KA) for cooperative binding is defined as the concentration of Apo3A at which half the input F-labeled DNA is bound. The KA and Hill coefficient parameters were calculated by fitting the data to a sigmoidal curve for cooperative binding using Sigma Plot 10.0 software. For non-cooperative binding, the data were fit to a rectangular hyperbola to obtain the apparent dissociation constant KD. The binding constants were determined from three independent experiments.
Analysis of Apo3A Deamination Specificity on ssDNA
Apo3A motif specificities were determined by measuring mutational spectra in a lacZα reporter contained in a ssDNA-gapped region of M13mp2 dsDNA, as described previously (36). M13mp2-gapped DNA (500 ng) was incubated with Apo3A (50 fmol at pH 5.5, 100 fmol at pH 6.5, and 1000 fmol at pH 8.0) in a 30-μl reaction volume, for 5 min at 37 °C. The reactions were quenched by a double extraction with phenol:chloroform:isoamyl alcohol (25:24:1). The DNA product was transfected into ung− Escherichia coli competent cells and plated on α-complementation host cells. Conversions of C → U on the DNA substrate were detected as C → T mutations in a lacZα target gene (36).
Deamination Activity and Motif Specificity for APOBEC Enzymes on Transcribed dsDNA
Transcription-dependent deamination on dsDNA was measured using a closed circular M13mp2 dsDNA substrate containing a T7 promoter. In a typical reaction (50 μl), 100 fmol of Apo3A, GST-AID, or Apo3G was incubated with 50 ng of dsDNA substrate, 10 units of T7 RNA polymerase (Promega), and four rNTPs (250 μm each) in a reaction buffer containing 40 mm Tris-HCl (pH 7.9), 6 mm MgCl2, 10 mm dithiothreitol, 10 mm NaCl, 2 mm spermidine, 0.05% Tween 20. Reactions were carried out for 30 min at 37 °C, and were quenched by extracting the product DNA twice with phenol:chloroform:isoamyl alcohol (25:24:1). The DNA was transfected into ung− E. coli competent cells and plated on α-complementation host cells. Conversions of C → U on the dsDNA substrate were detected as C → T mutations (deaminations on the non-transcribed strand) and G → A mutations (deaminations on the transcribed strand) in a lacZα target gene; mutants were scored by counting white or light blue M13 plaques; see e.g. Ref. 38.
RESULTS
As Apo3A functions biologically in significantly different environments, presumably at acidic pH in autophagosomes, and at physiological pH in nuclei, we set out to determine whether the response of the enzyme to pH might reflect its biological roles in a pH range spanning 5.1–8.0. Using ssDNA substrates, we have investigated the dependence on pH of Apo3A specific activity and substrate binding, motif specificity, and processivity. We have also measured transcription-dependent C deamination-initiated mutation spectra at pH 7.9 to determine whether a mutational signature linked to skin cancer might be observed.
Influence of pH on Apo3A Activity and Binding to ssDNA
Recombinant Apo3A containing six amino acids (GSPGID) at its N terminus was expressed in Sf9-infected insect cells and purified to chromatographic homogeneity (Fig. 1A). The enzyme behaves as a monomer in solution with an apparent molecular mass of 23 kDa (Fig. 1B).
A 65-nt ssDNA oligomer containing an internal fluorescein (F) label situated between two 5′-TC target motifs (Fig. 1C, top schematic) was used a substrate to measure Apo3A activity (Fig. 1, C and D) and binding (Fig. 2), at different pH values. The specific activity for Apo3A is optimal at pH 5.5 (626 pmol/min/μg), which is about 13-fold higher than at pH 7.4 (49 pmol/min/μg) (Fig. 1D). Along with single deaminations occurring at either 5′ or 3′ motifs, double deaminations are also observed at both 5′ and 3′ motifs at pH 5.5 and 6.5 (Fig. 1C). Notably, for the 1- and 2-min data points, less than 10% of the initial “intact” substrate is converted to product demonstrating, in accord with Poisson statistics, that a single bound Apo3A is responsible for catalyzing both deamination events prior to dissociation (39). Therefore, Apo3A is able to act processively as reported previously for AID and Apo3G (36, 39, 40). However, because of the 13–30-fold reduction in Apo3A activity, 5′ and 3′ correlated double deamination bands were not observed at pH 7.4 and 8.0 (Fig. 1C). Apo3A is indeed processive at these higher pH values, as we discuss below and shown in Fig. 3.
FIGURE 2.
pH-dependent binding of Apo3A to ssDNA. Apo3A binding to a fluorescein-labeled 65-nt ssDNA at pH 5.5, 6.5, 7.4, and 8.0 was measured by rotational anisotropy. The changes in rotational anisotropy with increasing Apo3A concentrations were fit to a sigmoidal binding curve (pH 5.1, 6.5, and 7.4) or a rectangular hyperbola binding curve (pH 8.0). Values for each data point represent the mean ± S.E., determined from 3 independent measurements.
FIGURE 3.
Apo3A C → U deamination spectra determined in a lacZα mutational reporter gene at pH 8.0, 6.5, and 5.5. A, percentage of clones containing 1 to 29 mutations. Apo3A-catalyzed C → U deaminations were detected as C → T mutations in lacZα (white or light blue M13 plaques). B, Apo3A deamination spectra were obtained by sequencing DNA from ∼100 individual mutant M13 clones at each pH. Colored bars represent the percentage of clones with C → T mutations at the position indicated on the lacZα sequence (−217 to +149). Red bars identify C deaminations occurring in 5′-TC motifs, blue bars represent 5′-CC motifs, and green bars represent 5′-RC motif (R = A or G). Arrows, shown at top and bottom, identify C sites, including the surrounding sequence context, exhibiting the largest pH-dependent change in deamination frequency.
The higher activity at acidic pH correlates with tighter binding (∼4-fold), comparing the apparent affinities, KA = 330 nm, pH 5.5 with KA = 1400 nm (pH 7.4) (Fig. 2). Apo3A has a net positive charge +7.1 at pH 5.5 and a net negative charge −2.5 at pH 7.4, which clearly accounts for its favored binding at acid pH (Fig. 2).
Although Apo3A behaves as a monomer in solution (Fig. 1B), a least squares fit of the binding data to a sigmoidal curve (Hill coefficients 1.5 to 1.6) is better than to a rectangular hyperbola indicating the possibility of weakly cooperative binding of Apo3A to ssDNA (Fig. 2), as was recently observed for wild type AID (37). Thus, despite purifying as monomer in solution, it is possible that Apo3A might be active on ssDNA as dimer, which might also be the case for AID (37) and Apo3G (41). Binding of Apo3A at pH 5.5 to dsDNA, to dsDNA containing 1, 3, 5, and 7 nt stretches of ssDNA bubbles and to short ssDNA (5 and 7 nt), showed considerably reduced affinities and no indication of cooperative binding (Table 1).
TABLE 1.
Apo3A binding to dsDNA, dsDNA containing an ssDNA bubble, and to ssDNA oligonucleotides, measured at pH 5.5
| Substratea | KDb |
|---|---|
| μm | |
| dsDNA | 5.40 ± 1.20 |
| 1-nt bubble | 2.81 ± 0.78 |
| 3-nt bubble | 1.22 ± 0.11 |
| 7-nt bubble | 0.62 ± 0.11 |
| 5-nt ssDNA | 2.95 ± 0.17 |
| 7-nt ssDNA | 0.91 ± 0.09 |
a Apo3A binding was measured by rotational anisotropy using a fluorescein-labeled 37-base pair dsDNA; a 37-base pair duplex DNA containing 1, 3, or 7 nt ssDNA bubble regions; 5-nt and 7-nt ssDNA substrates.
b KD was calculated by fitting the changes in rotational anisotropy with increasing Apo3A concentrations to a rectangular hyperbola.
A3A Motif Specificity Dependence on pH
The presence of a wide variety of tri- and tetranucleotide motifs that contain C permits the “lengthy” lacZα reporter gene (365 nt) to serve as an ideal target to ascertain APOBEC motif specificities (Fig. 3) (36). Here is a brief synopsis of the assay. Apo3A is incubated with phage M13mp2 circular DNA containing a single-stranded gap region containing the mutation reporter, which upon transfection in ung− E. coli, produces either C → T mutated white and light blue plaques or non-mutated dark blue plaques. The concentrations of enzyme, DNA, and incubation times are arranged so that the mutated targets comprise less than 5% of the total target DNA, which ensures that the C → T mutations determined by sequencing individual DNA clones originate from C → U deaminations catalyzed by just a single Apo3A molecule. The key point is that from 2 to about 30 mutations are present in >80% of the mutated clones (Fig. 3A), which means that Apo3A catalyzes processive deaminations, including at pH 8.0, where double deamination bands had not been detected in the F-labeled target motif cleavage assay (Fig. 1C).
5′-YYC (Y = pyrimidine) is by far the predominantly favored motif for deamination by Apo3A irrespective of pH, accounting for 9 of the 10 most favored motifs at pH 8.0, 6.5, and 5.5, the exceptions being TAC at pH 8.0 and GTC at pH 6.5 and 5.5 (Table 2). A YYC motif preference is consistent with reported higher activities of Apo3A at physiological pH on short oligonucleotide substrates containing a pyrimidine at the 5′-side of C (42–44). Yet the analysis of motif specificity yields the surprising observation that there are roughly half as many mutations per clone at pH 5.5 compared with pH 8.0 (Fig. 3B), even though Apo3A is 30-fold more active at pH 5.5 (Fig. 1, C and D). At pH 5.5 the large majority of clones (∼65%) contain 2 to 5 mutations compared with about 35% of the clones at pH 6.5 and 8.0 (Fig. 3A). Approximately 10% of the clones at pH 6.5 and 8.0 have more than 15 mutations, compared with none at pH 5.5 (Fig. 3A).
TABLE 2.
Apo3A motif deamination preferences at pH 8.0, 6.5, and 5.5
The 10 most mutated motifs are listed for each pH.
| pH 8.0 |
pH 6.5 |
pH 5.5 |
|||
|---|---|---|---|---|---|
| Motif | Frequencya | Motif | Frequency | Motif | Frequency |
| CTCG | 0.73 | CTCG | 0.64 | CCCA | 0.66 |
| TACA | 0.54 | CCCA | 0.64 | TCCG | 0.45 |
| CTCT | 0.50 | TCCG | 0.61 | CTCA | 0.30 |
| CTCC | 0.42 | CTCT | 0.36 | CTCA | 0.19 |
| TCCC | 0.33 | CCCG | 0.33 | TTCG | 0.15 |
| TCCG | 0.33 | CTCA | 0.33 | TTCA | 0.14 |
| CCCC | 0.31 | CTCC | 0.29 | CCCG | 0.12 |
| TTCG | 0.31 | CTCA | 0.26 | CTCG | 0.12 |
| CTCG | 0.27 | GTCG | 0.25 | GTCG | 0.11 |
| CCCG | 0.25 | TTCG | 0.23 | CTCT | 0.10 |
| YYC | Consensus | YYC | Consensus | YYCR | Consensus |
a Frequency represents fraction of clones containing deaminations in the indicated motifs. Y = pyrimidine; R = purine.
The explanation for these results appears to be that there is a significant reduction in the number of YYC consensus motifs that are deaminated with relatively high efficiency by Apo3A at pH 5.5 compared with pH 6.5 and 8.0 (Fig. 3B, Table 2). At pH 8.0 and 6.5, there are 10 YYC motifs that have undergone deamination in about 25% of the clones. In contrast, at pH 5.5, there are only three such motifs. Specifically, the non-YYC motif TAC, which is the second most favored motif at pH 8.0, undergoes deamination in 54% of the clones (Table 2), and, whereas not in the top 10, is still deaminated in 18% of the clones at pH 6.5 (Fig. 3B); in contrast, deamination at TAC occurs in less than 2% of the clones at pH 5.5 (Fig. 3B). There is therefore a considerable narrowing in the range of the most favored motifs at acidic pH, both YYC and non-YYC, which appears to be the explanation for the reduction in numbers of mutations per clone at pH 5.5 compared with pH 6.5 and 8.0.
There is an additional constraint on the consensus YYC at pH 5.5, in which 9 of the 10 most favored motifs contain a 3′ purine (R) compared with 6 of 10 at pH 8.0, and there are only 15 YYCR sites in the mutational target sequence further accounting for the reduction in mutations per clone at pH 5.5. Despite having reduced numbers of deaminations at pH 5.5, the range of enzyme motion covers the entire lacZα target to a similar extent because at least 40% of the clones at the each pH have mutations that span virtually the entire lacZα target; i.e. during a single Apo3A-ssDNA encounter each of these clones has a mutation near the 5′-end of lacZα and a mutation near the 3′-end of lacZα that is separated by between 300 and 365 nt (Fig. 4).
FIGURE 4.

Range of Apo3A C deaminations in a lacZα mutational target. The Apo3A scanning range on ssDNA occurring during a single enzyme-ssDNA binding event is defined as the largest distance between deaminated sites on individual clones containing ≥2 mutations. The mutations span the entire lacZα gene, and the range is similar for all values of pH. The lacZα mutational reporter gene contains 365 nt.
Linking Apo3A Motif Specificity at pH 8.0 to a Tandem CC → TT Skin Cancer Signature
The up-regulation of Apo3A expression in precancerous keratinocytes (21, 34, 35) suggests that its ability to deaminate C in ssDNA could be directly responsible for generating the types of tandem CC → TT mutations found in skin cancer. We have investigated whether Apo3A generates excess mutations at consecutive C sites using, as before, the lacZα target, which has 10 motifs containing from 2 to 5 consecutive C residues (Table 3). Consecutive deaminations in the lacZα target are frequently present at pH 6.5 and 8.0, with 78 and 63% of the clones having at least one CC → TT tandem double mutation at pH 6.5 and 8.0, respectively (Table 3). In contrast, very few clones (<10%) undergo deaminations at consecutive Cs at pH 5.5, which provides another clear indication of a strong dependence of motif specificity on pH.
TABLE 3.
A3A-catalyzed tandem deaminations in runs of consecutive C
| Sitesa | Fraction of clones with tandem mutations (%) |
|||
|---|---|---|---|---|
| pH 8.0 | pH 6.5 | pH 5.5 | Transcription (pH 7.9) | |
| GCCCG | 0.0 | 0.0 | 1.4 | N/Ab |
| ACCCT | 0.0 | 0.0 | 1.4 | N/A |
| GCCCA | 2.1 | 0.0 | 0.0 | N/A |
| TCCCCG | 33.3 | 28.9 | 0.0 | N/A |
| TCCCG | 2.1 | 4.4 | 0.0 | N/A |
| ACCCCA | 0.0 | 4.4 | 0.0 | 0 |
| TTCCG | 20.8 | 17.8 | 2.7 | 8.75 |
| GCCG | 0.0 | 1.1 | 0.0 | 0 |
| ACCCA | 2.1 | 7.8 | 4.1 | 3.75 |
| TCCCCCT | 2.1 | 13.3 | 0.0 | 16.25 |
| Total | 62.5 | 77.8 | 9.6 | 28.75 |
a Mutated sites are underlined.
b Because of the placement of the T7 promoter, these sites are not accessible for deamination by Apo3A in a dsDNA template undergoing transcription.
Although Apo3A is likely to be working on HIV-1 cDNA, it is probable that its action on genomic DNA occurs during transcription, and indeed the CC → TT mutations found in skin cancer occur exclusively on the non-transcribed strand (45, 46), even though there are numerous potential sites for mutation on the transcribed strand. We have used the M13-lacZα reporter assay to measure T7 RNA polymerase transcription-dependent Apo3A catalyzed deamination (Fig. 5). Apo3A is active on DNA undergoing transcription based on a 26-fold increase in M13 mutant phage frequency (124 × 10−4) over the background mutant frequency (4.8 × 10−4) (Table 4). Every one of the more than 200 C → T mutations detected by sequencing 80 mutant clones occurs on the non-transcribed strand; G → A mutations, which would result from deaminations on the transcribed strand, are absent from the spectrum (Fig. 5A).
FIGURE 5.
Apo3A transcription-dependent deaminations occur exclusively on the non-transcribed strand, featuring CC → TT tandem mutations a hallmark of skin cancer. A, Apo3A deamination spectrum on dsDNA transcribed by T7 RNA polymerase. Apo3A was incubated with a M13 dsDNA substrate (top schematic) in the presence of T7 RNA polymerase and four rNTPs at pH 7.9. C → U deaminations, are detected as C → T mutations in lacZα if deaminations occurred on the non-transcribed strand or as G → A mutations for deaminations on the transcribed strand. All 203 lacZα mutations were C → T, shown as stars (*). B, percentage of clones containing 1–8 mutations. C, the Apo3A scanning range on transcribed dsDNA occurring during a single enzyme-dsDNA binding event is defined as the largest distance between deaminated sites on individual clones containing ≥2 mutations.
TABLE 4.
Comparison of Apo3A, AID, and Apo3G activities in T7-RNA pol transcribed M13 dsDNA
Deamination activity is detected by the presence of mutant M13 phage (light blue or white plaques) caused by APOBEC C → U deamination in lacZα.
| M13 mutant phage frequency (×10−4) | |
|---|---|
| DNA alone | 4.2 ± 1.4 |
| DNA + T7 RNA pol | 4.8 ± 3.2 |
| DNA + T7 RNA pol +Apo3Aa | 124 ± 12 |
| DNA + T7 RNA pol +AID | 35.5 ± 5.8 |
| DNA + T7 RNA pol +Apo3G | 5.4 ± 2.9 |
a Apo3A, AID, or Apo3G (100 pmol each) were present in the reactions.
The deamination specificity during transcription at pH 7.9 shows the same prominent 5′-TACA motif, which was present on ssDNA at pH 8.0 (Fig. 3B, Table 2). Most importantly, tandem mutations at CC sites are clearly present in the spectrum in three runs of C, TTCCG, ACCCA, and most avidly in TCCCCCT, which occurs in 16% of the clones (Fig. 5A, Table 3). There is 1 mutation in 30% of the clones, 30% with 2 mutations, 18% with 3 mutations, 11% with 4 mutations, and about 11% with at least 5 mutations going out to 8 (Fig. 5B). The presence of mutations near the 5′- and 3′-ends of lacZα occurring in the same clone shows that Apo3A is able to remain bound and acts processively during the time that the entire lacZα target is being transcribed (Fig. 5C). Deaminations might be occurring either in a moving transcription bubble, or perhaps more likely in a bubble that is transiently stalled. We find that Apo3A has about the same deamination activity on a 7-nt bubble substrate compared with ssDNA, and retains small but measurable activity on 3- and 1-nt bubbles (Fig. 6).
FIGURE 6.

Comparison of Apo3A deamination activity on 37-nt ssDNA and 37-bp duplex DNA containing 7-nt bubble, 3-nt bubble, or a 1-nt bubble. Apo3A (1 to 8 pmol) was incubated with 10 pmol of a 32P-labeled ssDNA or bubble DNA substrates for 10 min at 37 °C (pH 8.0). Deamination products were separated by 16% denaturing PAGE, visualized, and quantified by PhosphorImaging.
DISCUSSION
This study makes a key connection linking the enzymatic properties of the ssDNA-dependent C deaminase Apo3A together with two seemingly disconnected biological events, the inactivation of HIV-1 in myeloid cells and the potentiation of skin lesions toward cancer. Apo3A is normally expressed in myeloid cells and has the potential to inactivate HIV-1 by deaminating C → U on cDNA (8–10), presumably analogous to the “attack” by Apo3G on HIV-1 cDNA in T cells (5–7). In skin lesions, e.g. acne and psoriasis, Apo3A is up-regulated with the possibility for causing serious “mutator” damage to cellular DNA (21, 34, 35). We have obtained biochemical evidence ascribing positive and negative biological roles to Apo3A, positive as an HIV-1 restriction factor in cells of myeloid lineage at acid pH, and negative as a potent mutator on genomic DNA in damaged keratinocytes at above neutral pH, which could portend skin cancer.
A Biochemical Basis for Inactivation of HIV-1 in Myeloid Cell Autophagosomal Compartments at Acid pH
A physiological pH range (7.0 to 7.8) is characteristic of nuclei and cytosolic regions for diverse cell types, with subtle differences such as a slightly more basic nuclear environment (47). Proteins such as those involved in nucleic acid transactions often mirror this environment, having optimal activities in a near-neutral pH range. In contrast, not so subtle differences occur in compartments of the endocytic pathway, which are acidic and where the pH decreases from about 6.5 in early endosomes to <6.0 in late endosomes, down to <5.5 in lysosomes (48). We have shown that Apo3A activity and motif recognition are strongly modified by pH, where the C deamination activity is optimal and motif specificity narrowest in acidic aqueous surroundings (Figs. 1 and 3, Table 2).
Cellular studies support an important role for Apo3A in restricting HIV-1; knockdown of Apo3A expression by siRNA or miR-shRNA is accompanied by a ∼5-fold increase in myeloid cell susceptibility to infection by HIV-1 (8, 9). Myeloid cells, composed of circulating monocytes, differentiated macrophage, and dendritic cells, are prime targets for HIV-1 replication. Apo3A is expressed in these cells, and most significantly is up-regulated concurrently with macrophage infection by HIV-1 (9). HIV-1 replication in macrophages requires the formation of autophagosomal enclosed membrane compartments (pH ∼5.8–6.1) (49–51).
Viral cDNA is reduced in interferon-treated myeloid cells, whereas concomitantly accumulating mutations in 5′-TC motifs, a clear indication that the induced Apo3A functions during an early phase of HIV-1 infection by deaminating C in reverse transcribed cDNA (9, 10, 12), the same as the action of Apo3G in T-cells (5–7). Yet there seems to be a basic distinction regarding where, and therefore perhaps how, Apo3A and Apo3G work because Apo3A shows no antiviral activity when overexpressed in HeLa and HEK293T cells, whereas Apo3G does (9, 52, 53).
But the different actions of Apo3A in myeloid cells and Apo3G in T-cells needs to be viewed in conjunction with the differing responses of the two types of HIV-1-infected cells to autophagy, which is the primary mechanism for degrading no longer functional cellular molecules and foreign substances. Autophagy is initiated by the formation of autophagosomes. Autophagosomes are double membrane vacuoles that can engulf deleterious cytoplasmic materials, which are then digested following fusion of autophagosomes with lysosomes (54). Autophagosomes in macrophages are characterized by their acidic environment (pH ∼5.8–6.1) before fusion with the lysosomes (55). There are contrasting responses of the two cell types to viral infection: whereas the presence of HIV-1 down-regulates autophagy in CD4 + T-cells (50, 56), the opposite occurs in macrophages where HIV-1 causes a marked increase in the numbers of autophagosomes in the cytoplasm, but inhibits the late proteolytic stage of autophagy involving lysosome fusion (49–51). The inhibition of autophagy in virus-infected macrophages substantially reduces HIV-1 production (50) suggesting that autophagy is needed for viral replication. Conversely, the induction of autophagy in macrophages is accompanied by increased virus production (49), suggesting that HIV-1 actually exploits autophagy enabling it to replicate more efficiently in the host myeloid cells.
So for Apo3A to eliminate the virus, it would presumably have to inhibit HIV-1 replication at the earliest stage of autophagy. Our speculative best guess is that Apo3A-mediated inactivation of HIV-1 is taking place in the enclosed acidic environment of the autophagosome (55), wherein, as our biochemical data reveal, Apo3A is optimally active (pH 5.1–6.5, Fig. 1D). The 13–30-fold increase in Apo3A-specific activity at acidic compared with near neutral pH values (pH 7.4–8.0) is accompanied by a significant narrowing of favored motif deamination specificity (Table 2). A rather strict 5′-YYCR motif specificity in the pH 5.5–6.1 range is consistent with the mutation pattern of HIV-1 (9, 10, 12), which also reflects the favored motif preference for Apo3G acting on HIV-1 cDNA in T cells (5–7). It has been reported recently that Apo3G has a more modest 4-fold increase in activity at acidic pH 5.5, compared with pH 7.4 (57). Thus, the Apo3A-catalyzed inactivation of HIV-1 in macrophages is fully compatible with its biochemical behavior. Notably, it has been shown that overexpression of Apo3A in HeLa or HEK293T cells shows no significant antiviral activity (9, 52, 53), which reinforces the biological relevance of the biochemical data, the strong activity of Apo3A at pH 5.1–6.5 is highly effective in eliminating HIV-1, whereas its weak activity at pH 7.4–8.0 is ineffective.
A Biochemical Basis for Apo3A Mutation Initiation in Precancerous Skin Lesions at Neutral pH
AID is active in B cell nuclei. When working “on target” physiologically, AID initiates SHM and CSR deaminating C → U in actively transcribed Ig V and S regions, respectively (3, 4). But AID also apparently acts off target on non-Ig loci, to generate translocations and deletions implicated in B-cell lymphomas (32), and to mutate 5′ regulatory regions of proto-oncogenes that alter transcription activities contributing to B-cell malignant transformation (33). The other APOBEC deaminases function predominantly in the cytoplasm, for example, cDNA of HIV-1 was acted on by Apo3A in macrophage and A3G in T cells. Yet, there is definitive evidence that these can also enter nuclei and attack ssDNA regions of genomic data for no good purpose, i.e. to potentiate and perhaps even to directly initiate cancer.
DNAs sequenced from breast cancers contain localized hypermutated regions (termed “kataegis”) with mutational clusters on the same DNA strand separated by a few to a few hundred nucleotides (58). The mutational clusters are distributed differently for different malignant cell types but typically share an APOBEC-like 5′-TC favored deamination motif signature (58). Based on protein expression levels taken in conjunction with a 5′-TC → 5′-TT mutational signature, it has been proposed that genomic off targeting by Apo3B is, in part, responsible for the occurrence of breast cancer (30). When expressed individually in yeast, AID, Apo3A, Apo3B, and lamprey APOBEC generate similar looking mutational clusters (31, 59, 60), which we would attribute to two features of APOBEC deaminases, first, a very simple shared motif recognition sequence, and second, the shared property of processivity ensuring that several and often many deaminations can be catalyzed by the same enzyme during a single APOBEC-ssDNA binding event. Processive catalysis by APOBECs has been shown biochemically to generate single along with short and long clusters of mutations for AID, Apo3G (36, 38, 61), and in this study for Apo3A.
The up-regulation of Apo3A in damaged skin lesions suggests that it might be implicated early on in initiating skin cancer. The key biochemical data supporting a fundamental role for Apo3A in initiating skin cancer is its telltale skin cancer signature, the CC → TT tandem mutations, in the pH 7.4–8.0 range (Table 3). Apo3A, especially when overproduced, could gain access to transient regions of single-stranded genomic DNA generated during DNA repair, or more likely perhaps during active gene transcription. Our data show the substantial presence of Apo3A-catalyzed CC → TT mutations on ssDNA (Table 3), and most importantly on dsDNA undergoing transcription (Fig. 5A, Table 3). We suggest that a large increase in the range of Apo3A motif preferences at basic compared with acidic pH, including most prominently mutations in runs of consecutive Cs at pH 6.5 and 8.0, virtually absent at pH 5.5 (Table 3), enables Apo3A to generate off target genomic mutations despite its 30-fold reduction in activity and ∼4-fold weaker binding to DNA at basic pH (Figs. 1D and 2).
Apo3A is highly processive when acting on ssDNA in acidic and basic milieu (Figs. 3A, B). Similar to AID, Apo3A maintains strong processivity during transcription of dsDNA (Fig. 5, A and B), reinforced by the observation that mutations occurring during transcription cover the entire lacZ reporter gene, immediately downstream from the promoter to the end of gene (Fig. 5). Thus, in a single binding event, Apo3A appears to track along with a moving transcription bubble, whereas deaminating the C → U on the non-transcribed strand exclusively (Fig. 5A). The biochemical data are consistent with the biological data showing that 100% of the CC → TT tandem mutations in skin cancer cells occur on the non-transcribed strand (45). The presence of substantial numbers of CC → TT mutations in skin cancer (45, 46) suggests to us that to the extent that tandem mutations are taking place in actively transcribed genes, that Apo3A is probably not acting on a moving transcription bubble, because of the extremely small likelihood to have consecutive deaminations occurring in a rapidly moving bubble, ∼100 nt/s. Instead, we speculate that perhaps most of the deaminations, single and especially double deaminations, take place on a transiently stalled bubble. The activity of Apo3A on a 7-nt bubble substrate is indistinguishable from its activity on ssDNA (Fig. 6).
The biological and biochemical linkage of Apo3A to skin cancer suggests a reevaluation of the longstanding model that the cyclobutane CC dimers that result from exposure of skin to sunlight undergo spontaneous deamination at both C residues (45, 46, 62). Perhaps a substantial fraction of the deaminations at C, and especially at neighboring Cs, are instead enzymatically caused by overproduced Apo3A in precancerous skin lesions acting on normal C residues. There is, for example, evidence suggesting that the spontaneous deamination of UV-induced DNA photoproducts may be insufficient to explain the formation of the tandem mutations in mammalian cells (46). Cells exposed first to UV light and then to oxidants (H2O2) or antioxidants (N-acetylcysteine, trolox) undergo substantially increased levels of CC → TT mutations that was attributed to a putative inducible “factor” (46). Apo3A off targeting of genomic DNA could provide a plausible enzymatic basis to explain how commonly occurring non-cancerous skin lesions are converted to precancerous lesions that subsequently become cancerous.
Acknowledgment
We thank Kathleen Chao for the assistance in construction of the Apo3A expression plasmid.
This work was supported, in whole or in part, by National Institutes of Health Grants GM21422 and ES013192.
- AID
- activation-induced deoxycytidine deaminase
- Apo3A
- APOBEC3A
- Apo3G
- APOBEC3G
- ssDNA
- single-stranded DNA
- dsDNA
- double-stranded DNA
- nt
- nucleotide
- miR
- microRNA.
REFERENCES
- 1. Jaszczur M., Bertram J. G., Pham P., Scharff M. D., Goodman M. F. (2013) AID and Apobec3G haphazard deamination and mutational diversity. Cell. Mol. Life Sci. 70, 3089–3108 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Chiu Y. L., Greene W. C. (2008) The APOBEC3 cytidine deaminases. An innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol. 26, 317–353 [DOI] [PubMed] [Google Scholar]
- 3. Di Noia J. M., Neuberger M. S. (2007) Molecular mechanisms of antibody somatic hypermutation. Annu. Rev. Biochem. 76, 1–22 [DOI] [PubMed] [Google Scholar]
- 4. Peled J. U., Kuang F. L., Iglesias-Ussel M. D., Roa S., Kalis S. L., Goodman M. F., Scharff M. D. (2008) The biochemistry of somatic hypermutation. Annu. Rev. Immunol. 26, 481–511 [DOI] [PubMed] [Google Scholar]
- 5. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., Trono D. (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99–103 [DOI] [PubMed] [Google Scholar]
- 6. Zhang H., Yang B., Pomerantz R. J., Zhang C., Arunachalam S. C., Gao L. (2003) The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424, 94–98 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Lecossier D., Bouchonnet F., Clavel F., Hance A. J. (2003) Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300, 1112. [DOI] [PubMed] [Google Scholar]
- 8. Peng G., Greenwell-Wild T., Nares S., Jin W., Lei K. J., Rangel Z. G., Munson P. J., Wahl S. M. (2007) Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood 110, 393–400 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Berger G., Durand S., Fargier G., Nguyen X. N., Cordeil S., Bouaziz S., Muriaux D., Darlix J. L., Cimarelli A. (2011) APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells. PLoS Pathog. 7, e1002221. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Koning F. A., Goujon C., Bauby H., Malim M. H. (2011) Target cell-mediated editing of HIV-1 cDNA by APOBEC3 proteins in human macrophages. J. Virol. 85, 13448–13452 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Goujon C., Malim M. H. (2010) Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells. J. Virol. 84, 9254–9266 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Cheney K. M., McKnight Á. (2010) Interferon-alpha mediates restriction of human immunodeficiency virus type-1 replication in primary human macrophages at an early stage of replication. PLoS One 5, e13521. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Chen H., Lilley C. E., Yu Q., Lee D. V., Chou J., Narvaiza I., Landau N. R., Weitzman M. D. (2006) APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Curr. Biol. 16, 480–485 [DOI] [PubMed] [Google Scholar]
- 14. Koning F. A., Newman E. N., Kim E. Y., Kunstman K. J., Wolinsky S. M., Malim M. H. (2009) Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J. Virol. 83, 9474–9485 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Thielen B. K., McNevin J. P., McElrath M. J., Hunt B. V., Klein K. C., Lingappa J. R. (2010) Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms. J. Biol. Chem. 285, 27753–27766 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Refsland E. W., Stenglein M. D., Shindo K., Albin J. S., Brown W. L., Harris R. S. (2010) Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues. Implications for HIV-1 restriction. Nucleic Acids Res. 38, 4274–4284 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Aynaud M. M., Suspène R., Vidalain P. O., Mussil B., Guétard D., Tangy F., Wain-Hobson S., Vartanian J. P. (2012) Human Tribbles 3 protects nuclear DNA from cytidine deamination by APOBEC3A. J. Biol. Chem. 287, 39182–39192 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Land A. M., Law E. K., Carpenter M. A., Lackey L., Brown W. L., Harris R. S. (2013) Endogenous APOBEC3A DNA cytosine deaminase is cytoplasmic and nongenotoxic. J. Biol. Chem. 288, 17253–17260 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Lackey L., Law E. K., Brown W. L., Harris R. S. (2013) Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination. Cell Cycle 12, 762–772 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Suspène R., Aynaud M. M., Guétard D., Henry M., Eckhoff G., Marchio A., Pineau P., Dejean A., Vartanian J. P., Wain-Hobson S. (2011) Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc. Natl. Acad. Sci. U.S.A. 108, 4858–4863 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Vartanian J. P., Guétard D., Henry M., Wain-Hobson S. (2008) Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science 320, 230–233 [DOI] [PubMed] [Google Scholar]
- 22. Narvaiza I., Linfesty D. C., Greener B. N., Hakata Y., Pintel D. J., Logue E., Landau N. R., Weitzman M. D. (2009) Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase. PLoS Pathog. 5, e1000439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Wiegand H. L., Cullen B. R. (2007) Inhibition of alpharetrovirus replication by a range of human APOBEC3 proteins. J. Virol. 81, 13694–13699 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Ooms M., Krikoni A., Kress A. K., Simon V., Münk C. (2012) APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1. J. Virol. 86, 6097–6108 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Stenglein M. D., Burns M. B., Li M., Lengyel J., Harris R. S. (2010) APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat. Struct. Mol. Biol. 17, 222–229 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Bogerd H. P., Wiegand H. L., Hulme A. E., Garcia-Perez J. L., O'Shea K. S., Moran J. V., Cullen B. R. (2006) Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc. Natl. Acad. Sci. U.S.A. 103, 8780–8785 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Kinomoto M., Kanno T., Shimura M., Ishizaka Y., Kojima A., Kurata T., Sata T., Tokunaga K. (2007) All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Res. 35, 2955–2964 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Bulliard Y., Narvaiza I., Bertero A., Peddi S., Röhrig U. F., Ortiz M., Zoete V., Castro-Díaz N., Turelli P., Telenti A., Michielin O., Weitzman M. D., Trono D. (2011) Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities. J. Virol. 85, 1765–1776 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Landry S., Narvaiza I., Linfesty D. C., Weitzman M. D. (2011) APOBEC3A can activate the DNA damage response and cause cell-cycle arrest. EMBO Rep. 12, 444–450 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Burns M. B., Lackey L., Carpenter M. A., Rathore A., Land A. M., Leonard B., Refsland E. W., Kotandeniya D., Tretyakova N., Nikas J. B., Yee D., Temiz N. A., Donohue D. E., McDougle R. M., Brown W. L., Law E. K., Harris R. S. (2013) APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494, 366–370 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Taylor B. J., Nik-Zainal S., Wu Y. L., Stebbings L. A., Raine K., Campbell P. J., Rada C., Stratton M. R., Neuberger M. S. (2013) DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. Elife 2, e00534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Klein I. A., Resch W., Jankovic M., Oliveira T., Yamane A., Nakahashi H., Di Virgilio M., Bothmer A., Nussenzweig A., Robbiani D. F., Casellas R., Nussenzweig M. C. (2011) Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes. Cell 147, 95–106 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Jiang Y., Soong T. D., Wang L., Melnick A. M., Elemento O. (2012) Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphoma. PLoS One 7, e40332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Madsen P., Anant S., Rasmussen H. H., Gromov P., Vorum H., Dumanski J. P., Tommerup N., Collins J. E., Wright C. L., Dunham I., MacGinnitie A. J., Davidson N. O., Celis J. E. (1999) Psoriasis upregulated phorbolin-1 shares structural but not functional similarity to the mRNA-editing protein apobec-1. J. Invest. Dermatol. 113, 162–169 [DOI] [PubMed] [Google Scholar]
- 35. Trivedi N. R., Gilliland K. L., Zhao W., Liu W., Thiboutot D. M. (2006) Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling. J. Invest. Dermatol. 126, 1071–1079 [DOI] [PubMed] [Google Scholar]
- 36. Pham P., Bransteitter R., Petruska J., Goodman M. F. (2003) Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 424, 103–107 [DOI] [PubMed] [Google Scholar]
- 37. Mu Y., Prochnow C., Pham P., Chen X. S., Goodman M. F. (2012) A structural basis for the biochemical behavior of activation-induced deoxycytidine deaminase class-switch recombination-defective hyper-IgM-2 mutants. J. Biol. Chem. 287, 28007–28016 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Pham P., Calabrese P., Park S. J., Goodman M. F. (2011) Analysis of a single-stranded DNA-scanning process in which activation-induced deoxycytidine deaminase (AID) deaminates C to U haphazardly and inefficiently to ensure mutational diversity. J. Biol. Chem. 286, 24931–24942 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Pham P., Chelico L., Goodman M. F. (2007) DNA deaminases AID and APOBEC3G act processively on single-stranded DNA. DNA Repair 6, 689–692; author reply 693–694 [DOI] [PubMed] [Google Scholar]
- 40. Chelico L., Pham P., Calabrese P., Goodman M. F. (2006) APOBEC3G DNA deaminase acts processively 3′ → 5′ on single-stranded DNA. Nat. Struct. Mol. Biol. 13, 392–399 [DOI] [PubMed] [Google Scholar]
- 41. Chelico L., Sacho E. J., Erie D. A., Goodman M. F. (2008) A model for oligomeric regulation of APOBEC3G cytosine deaminase-dependent restriction of HIV. J. Biol. Chem. 283, 13780–13791 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Love R. P., Xu H., Chelico L. (2012) Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A. J. Biol. Chem. 287, 30812–30822 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Carpenter M. A., Li M., Rathore A., Lackey L., Law E. K., Land A. M., Leonard B., Shandilya S. M., Bohn M. F., Schiffer C. A., Brown W. L., Harris R. S. (2012) Methylcytosine and normal cytosine deamination by the foreign DNA restriction enzyme APOBEC3A. J. Biol. Chem. 287, 34801–34808 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Byeon I. J., Ahn J., Mitra M., Byeon C. H., Hercík K., Hritz J., Charlton L. M., Levin J. G., Gronenborn A. M. (2013) NMR structure of human restriction factor APOBEC3A reveals substrate binding and enzyme specificity. Nat. Commun. 4, 1890. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Giglia-Mari G., Sarasin A. (2003) TP53 mutations in human skin cancers. Hum. Mutat. 21, 217–228 [DOI] [PubMed] [Google Scholar]
- 46. Skinner A. M., Turker M. S. (2008) High frequency induction of CC to TT tandem mutations in DNA repair-proficient mammalian cells. Photochem. Photobiol. 84, 222–227 [DOI] [PubMed] [Google Scholar]
- 47. Seksek O., Bolard J. (1996) Nuclear pH gradient in mammalian cells revealed by laser microspectrofluorimetry. J. Cell Sci. 109, 257–262 [DOI] [PubMed] [Google Scholar]
- 48. Demaurex N. (2002) pH Homeostasis of cellular organelles. News Physiol. Sci. 17, 1–5 [DOI] [PubMed] [Google Scholar]
- 49. Kyei G. B., Dinkins C., Davis A. S., Roberts E., Singh S. B., Dong C., Wu L., Kominami E., Ueno T., Yamamoto A., Federico M., Panganiban A., Vergne I., Deretic V. (2009) Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J. Cell Biol. 186, 255–268 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Espert L., Varbanov M., Robert-Hebmann V., Sagnier S., Robbins I., Sanchez F., Lafont V., Biard-Piechaczyk M. (2009) Differential role of autophagy in CD4 T cells and macrophages during X4 and R5 HIV-1 infection. PLoS One 4, e5787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Killian M. S. (2012) Dual role of autophagy in HIV-1 replication and pathogenesis. AIDS Res. Ther. 9, 16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Bishop K. N., Holmes R. K., Sheehy A. M., Davidson N. O., Cho S. J., Malim M. H. (2004) Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 14, 1392–1396 [DOI] [PubMed] [Google Scholar]
- 53. Doehle B. P., Schäfer A., Wiegand H. L., Bogerd H. P., Cullen B. R. (2005) Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion. J. Virol. 79, 8201–8207 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Xie Z., Klionsky D. J. (2007) Autophagosome formation. Core machinery and adaptations. Nat. Cell Biol. 9, 1102–1109 [DOI] [PubMed] [Google Scholar]
- 55. Lukacs G. L., Rotstein O. D., Grinstein S. (1990) Phagosomal acidification is mediated by a vacuolar-type H+-ATPase in murine macrophages. J. Biol. Chem. 265, 21099–21107 [PubMed] [Google Scholar]
- 56. Zhou D., Spector S. A. (2008) Human immunodeficiency virus type-1 infection inhibits autophagy. AIDS 22, 695–699 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Harjes S., Solomon W. C., Li M., Chen K. M., Harjes E., Harris R. S., Matsuo H. (2013) Impact of H216 on the DNA binding and catalytic activities of the HIV restriction factor APOBEC3G. J. Virol. 87, 7008–7014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Nik-Zainal S., Alexandrov L. B., Wedge D. C., Van Loo P., Greenman C. D., Raine K., Jones D., Hinton J., Marshall J., Stebbings L. A., Menzies A., Martin S., Leung K., Chen L., Leroy C., Ramakrishna M., Rance R., Lau K. W., Mudie L. J., Varela I., McBride D. J., Bignell G. R., Cooke S. L., Shlien A., Gamble J., Whitmore I., Maddison M., Tarpey P. S., Davies H. R., Papaemmanuil E., Stephens P. J., McLaren S., Butler A. P., Teague J. W., Jönsson G., Garber J. E., Silver D., Miron P., Fatima A., Boyault S., Langerød A., Tutt A., Martens J. W., Aparicio S. A., Borg Å., Salomon A. V., Thomas G., Børresen-Dale A. L., Richardson A. L., Neuberger M. S., Futreal P. A., Campbell P. J., Stratton M. R. (2012) Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979–993 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Lada A. G., Dhar A., Boissy R. J., Hirano M., Rubel A. A., Rogozin I. B., Pavlov Y. I. (2012) AID/APOBEC cytosine deaminase induces genome-wide kataegis. Biol. Direct 7, 47; discussion 47 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Roberts S. A., Sterling J., Thompson C., Harris S., Mav D., Shah R., Klimczak L. J., Kryukov G. V., Malc E., Mieczkowski P. A., Resnick M. A., Gordenin D. A. (2012) Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. Mol. Cell 46, 424–435 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Senavirathne G., Jaszczur M., Auerbach P. A., Upton T. G., Chelico L., Goodman M. F., Rueda D. (2012) Single-stranded DNA scanning and deamination by APOBEC3G cytidine deaminase at single molecule resolution. J. Biol. Chem. 287, 15826–15835 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Peng W., Shaw B. R. (1996) Accelerated deamination of cytosine residues in UV-induced cyclobutane pyrimidine dimers leads to CC→TT transitions. Biochemistry 35, 10172–10181 [DOI] [PubMed] [Google Scholar]




